Delivery Order SPE2DB20D7059-SPE2DB24FPVW6
Award Date 12/14/23
Potential Completion Date 12/15/23
Potential Value $3.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,156.27, is for the delivery of BREVIBLOC 2,500 MG/250 ML BAG 250ML medical supplies. The contract is a Firm Fixed Price Delivery Order that runs through April 4, 2025. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of BREVIBLOC 2,000 MG/100 ML BAG 100ML, a pharmaceutical product. The delivery order is valued at $9,995.45 and has a firm fixed price. The contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $2,289.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BREVIBLOC 2,500 MG/250 ML BAG 250ML, a medical product, with a period of performance ending on September 3, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999...
- This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of BREVIBLOC 2,500 MG/250 ML BAG 250ML, a pharmaceutical product, with a ceiling value of $1,165.88. The contract is a firm fixed-price delivery order and is not set aside for any specific business category. Amerisourcebergen Drug Corp is the prime contractor for this award and holds a larger...
- The Defense Logistics Agency awarded a $1,226.73 delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Brevibloc 2,000 mg/100 ml bags. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of June 30, 2025. The product will be delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA...
- This is a $3,086.16 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The order is for 4,560,594,597 units of the pharmaceutical product BREVIBLOC 2,500 MG/250 ML BAG 250ML. This order is not associated with a set-aside program. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract, with a potential value of $1,029.72, is for the supply of BREVIBLOC 100 MG/10 ML VIAL 10ML, a pharmaceutical product. No set-aside designation was used. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA,...
- The Defense Logistics Agency awarded a delivery order valued at $2,513.46 to AmerisourceBergen Drug Corp for the supply of BREVIBLOC 2,500 mg/250 ml intravenous medication in 250 ml bags. The award was issued on May 8, 2025, with an ultimate completion date of May 9, 2025, and was made on a firm fixed-price basis without set-aside designation. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine...
- The Defense Logistics Agency awarded a $3,633.30 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 2,500 milligrams/250 milliliters of BREVIBLOC bags. The prime contractor will deliver the pharmaceutical product from its Conshohocken, Pennsylvania location to fulfill the Defense Logistics Agency's requirements by August 4, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global supply chain for the United...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $7,091.13, is for the delivery of Bridion 200 mg/2 ml vials, a medical product used in healthcare settings. This is a firm-fixed-price delivery order contract with a completion date of June 21, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...